Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Cancers
|
June 13, 2020
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
Maelle Le Thiec, Aude Testard, Ludovic Ferrer, et al.
Medicina (Kaunas, Lithuania)
|
February 25, 2023
Unusual Association of Diamond-Blackfan Anemia and Severe Sinus Bradycardia in a Six-Month-Old White Infant: A Case Report and Literature Review
Stefana Maria Moisa, Elena-Lia Spoiala, Laura Mihaela Trandafir, et al.
The Lancet. Diabetes & Endocrinology
|
May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
Martin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
Clinical Nuclear Medicine
|
June 24, 2024
Pilot Feasibility Study: 18 F-DPA-714 PET/CT Macrophage Imaging in Triple-Negative Breast Cancers (EITHICS)
Caroline Rousseau, Raphaël Metz, Olivier Kerdraon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 7, 2018
Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod)
Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial
Isabelle Borget, Julia Bonastre, Bogdan Catargi, et al.
The New England Journal of Medicine
|
March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer
Sophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
The Lancet. Diabetes & Endocrinology
|
November 25, 2024
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial
Sophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Cancers
|
June 13, 2020
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
Maelle Le Thiec, Aude Testard, Ludovic Ferrer, et al.
Medicina (Kaunas, Lithuania)
|
February 25, 2023
Unusual Association of Diamond-Blackfan Anemia and Severe Sinus Bradycardia in a Six-Month-Old White Infant: A Case Report and Literature Review
Stefana Maria Moisa, Elena-Lia Spoiala, Laura Mihaela Trandafir, et al.
The Lancet. Diabetes & Endocrinology
|
May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
Martin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
Clinical Nuclear Medicine
|
June 24, 2024
Pilot Feasibility Study: 18 F-DPA-714 PET/CT Macrophage Imaging in Triple-Negative Breast Cancers (EITHICS)
Caroline Rousseau, Raphaël Metz, Olivier Kerdraon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 7, 2018
Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod)
Laurence Leenhardt, Sophie Leboulleux, Claire Bournaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial
Isabelle Borget, Julia Bonastre, Bogdan Catargi, et al.
The New England Journal of Medicine
|
March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer
Sophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
The Lancet. Diabetes & Endocrinology
|
November 25, 2024
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial
Sophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Page
of 6